Fig. 1From: Pleuroparenchymal fibroelastosis in rheumatoid arthritis-associated interstitial lung diseaseComparison of survival between the PPFE and no-PPFE groups in patients with RA-ILD. A Survival curves of patients with PPFE and those without. The median survival did not significantly differ between patients with PPFE and those without (8.4 vs. 10.4 years; p = 0.295). B Survival curves of patients with limited and extensive PPFE, as well as those without. Patients with extensive PPFE showed a trend for worse survival (median survival: 6.2 years) than those with limited PPFE (median survival: 8.4 years; p = 0.057) and significantly worse survival than those without PPFE (median survival: 10.4 years; p = 0.029). PPFE pleuroparenchymal fibroelastosisBack to article page